Acessibilidade
A+
A-
Institucional
EN
PT
2030 Commitments
Material Topics
GRI
SASB
TCFD
Ratings
MSCI
Policies
SASB
Home
>
SASB
>
Patient health outcomes
>
HC-DR-260b.3
Data pertaining to 2025
Overview
Retail energy management
Controlled substances management
Medicine supply chain integrity
Activity metrics
Patient health outcomes
Data security and privacy
Patient health outcomes
Choose a disclosure
HC-DR-260b.1
HC-DR-260b.2
HC-DR-260b.3
GRI HC-DR-260b.3
Total amount of monetary losses as a result of legal proceedings associated with prescription dispensing errors
BRL 310,180.21
© 2026 RaiaDrogasil – Todos os direitos reservados.
Produzido por
Plank